Evolus, Inc. (EOLS) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evolus, Inc. Common Stock.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.794 Good afternoon, everyone, and thank you for standing by. 00:00:02.794 -- 00:00:07.038 Welcome to Evalyst's second quarter earnings conference call. 00:00:07.038 -- 00:00:12.163 If you require operator assistance during the conference, please press star zero. 00:00:12.163 -- 00:00:17.308 As a reminder, today's conference is being recorded and webcast live. 00:00:17.308 -- 00:00:20.391 All participants are in a listen-only mode. 00:00:20.391 -- 00:00:24.636 After the speaker's remarks, there will be a question and answer session. 00:00:24.636 -- 00:00:29.710 I would now like to turn the conference over to Narek Segarian, Vice President, and 00:00:29.710 -- 00:00:34.195 Head of Global Investor Relations and Corporate Communications. 00:00:34.195 -- 00:00:36.636 Please go ahead. 00:00:37.439 -- 00:00:41.724 Thank you, Operator, and welcome to everyone joining us on today's call to review Evelis' 00:00:41.724 -- 00:00:46.950 second quarter financial results. Our second quarter press release is now on our website 00:00:46.950 -- 00:00:49.052 at evelis.com. 00:00:49.052 -- 00:00:53.837 With me today are David Modazzetti, President and Chief Executive Officer, and Louis 00:00:53.837 -- 00:00:57.423 Avalar, Chief Medical Officer and Head of R&D. 00:00:57.423 -- 00:01:00.547 Today's call will include forward-looking statements. 00:01:00.547 -- 00:01:05.174 Actual results may differ materially due to risks and uncertainties outlined in our earnings 00:01:05.174 -- 00:01:07.917 press release and SEC filings. 00:01:07.917 -- 00:01:11.903 These forward-looking statements are based on current assumptions, and we undertake no 00:01:11.903 -- 00:01:14.587 obligation to update them. 00:01:14.587 -- 00:01:18.692 Additionally, we will discuss certain ...